Cost-benefit analysis of a population-based prostate-specific antigen mass testing for early detection of prostate cancer in Anambra State, Nigeria: A health provider's perspective
I. Umeh, C. Ogbuagu, C. Okafor, V. Abhulimen, Joseph Abiahu, A. Biambo, A. Isah, O. Ekwunife
{"title":"Cost-benefit analysis of a population-based prostate-specific antigen mass testing for early detection of prostate cancer in Anambra State, Nigeria: A health provider's perspective","authors":"I. Umeh, C. Ogbuagu, C. Okafor, V. Abhulimen, Joseph Abiahu, A. Biambo, A. Isah, O. Ekwunife","doi":"10.4103/njm.njm_122_22","DOIUrl":null,"url":null,"abstract":"Aims: We conducted a cost-benefit analysis of a population-based prostate-specific antigen (PSA) mass testing for prostate cancer (PCa) from a provider's perspective to give further insights into the programme's sustainability at scale-up. Materials and Methods: A cross-sectional study design was adopted. The cost and benefit of the population-based-specific antigen mass testing were estimated using activity-based costing and participants' willingness to pay (WTP), respectively. The study was conducted in a primary health-care facility in Anambra State, Nigeria. A total of 412 asymptomatic males between 40 and 74 years who had not had a PSA screening within the past five years were recruited for the study. A one-month population-based PSA mass screening for PCa was performed at the primary health-care facility. The cost of population-based PSA mass testing was presented as cost/male screened while benefit was measured as the participants' minimum WTP analysis amount. Benefit-cost ratio (BCR) served as the primary outcome, with values higher than one signifying a self-sustainable programme. Results: The cost/male screened was USD 13.43 ± 2.26, while the participants' WTP amount of US$3.99 ± 4.49 to calculate the BCR gave a BCR ratio of 0.3. Conclusion: The estimated BCR showed that the programme would not be sustainable if funding were based solely on participants' out-of-pocket expenses. Other financing mechanisms, such as donor funds, will be necessary to sustain such public health programmes in Nigeria.","PeriodicalId":52572,"journal":{"name":"Nigerian Journal of Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nigerian Journal of Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/njm.njm_122_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: We conducted a cost-benefit analysis of a population-based prostate-specific antigen (PSA) mass testing for prostate cancer (PCa) from a provider's perspective to give further insights into the programme's sustainability at scale-up. Materials and Methods: A cross-sectional study design was adopted. The cost and benefit of the population-based-specific antigen mass testing were estimated using activity-based costing and participants' willingness to pay (WTP), respectively. The study was conducted in a primary health-care facility in Anambra State, Nigeria. A total of 412 asymptomatic males between 40 and 74 years who had not had a PSA screening within the past five years were recruited for the study. A one-month population-based PSA mass screening for PCa was performed at the primary health-care facility. The cost of population-based PSA mass testing was presented as cost/male screened while benefit was measured as the participants' minimum WTP analysis amount. Benefit-cost ratio (BCR) served as the primary outcome, with values higher than one signifying a self-sustainable programme. Results: The cost/male screened was USD 13.43 ± 2.26, while the participants' WTP amount of US$3.99 ± 4.49 to calculate the BCR gave a BCR ratio of 0.3. Conclusion: The estimated BCR showed that the programme would not be sustainable if funding were based solely on participants' out-of-pocket expenses. Other financing mechanisms, such as donor funds, will be necessary to sustain such public health programmes in Nigeria.
期刊介绍:
The Nigerian Journal of Medicine publishes articles on socio-economic, political and legal matters related to medical practice; conference and workshop reports and medical news.